Clinical trial
Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
NCT06477406 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
- Lead sponsor
- Mclean Hospital
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- February 27, 2024
- Completion date
- December 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.